Behind the Campaign to Can Quorn

Fumento, Michael
November 2002
Consumers' Research Magazine;Nov2002, Vol. 85 Issue 11, p34
Deals with the lobbying efforts of the Center for Science in the Public Interest (CSPI) in the U.S. against Quorn, a meat alternative product from Marlow Foods Limited. Complaints of CSPI to the Food and Drug Administration on the alleged adverse reactions of consumers to Quorn; Comments from former FDA Director of the Center for Food Safety and Applied Nutrition Sanford Miller on the safety of Quorn; Importance of Quorn for vegetarians.


Related Articles

  • misleading meat substitute. Haar, Kristina // Joe Weider's Muscle & Fitness Hers;Jul2003, Vol. 4 Issue 5, p16 

    Reports the governmental review into Quorn, a meat substitute, by the U.S. Food and Drug Administration in July 2003.

  • Brand slurs for vegetarians. Mortimer, Ruth // Brand Strategy;Sep2002, Issue 163, p9 

    Reports that the U.S.-based consumer group Center for Science in the Public Interest (CSPI) calls for the withdrawal from the market of Marlow Foods' Quorn meat substitute brand. Great Britain-based Advertising Standards Authority's ruling in favor of the misleading advertisement complaint...

  • Quorn to roll out across Europe. McCawley, Ian // Marketing Week;3/1/2001, Vol. 24 Issue 3, p11 

    Reports that Marlow Foods will launch its meat substitute brand Quorn in Europe. Market position of Quorn in Great Britain; Growth of the European market for meat-free foods.

  • Can Quorn win over the healthy meat-eaters? Kleinman, Mark // Marketing (00253650);7/17/2003, p13 

    Marlow Foods Ltd. hopes that turning Quorn into a mainstream healthy-eating brand will revive interest in the meat alternative. Marlow Foods, recently acquired by buy-out firm, Montagu Private Equity from AstraZeneca, is the manufacturer of Quorn, Great Britain's biggest meat-free brand. Over...

  • Quorn needs meaty backer to tempt US. McCawley, Ian // Marketing Week;9/7/2000, Vol. 23 Issue 32, p20 

    Comments on Great Britain-based Marlow Foods' plan to launch its Quorn brand of meat substitute in the United States as of September 7, 2000. Background on the growth of the vegetarian food industry in Great Britain; Problems faced by Marlow Foods in marketing Quorn in the U.S.

  • SELLING SUBSTITUTES TO A SUSPICIOUS NATION. Butler, Daniel // Accountancy;Oct92, Vol. 110 Issue 1190, p34 

    Reports on Marlow Foods' attempt to introduce Quorn to the British food market. Company's research into meat alternatives; Unlimited potential of Quorn; Sales performance of Marlow Foods.

  • Postmarket surveillance for medical devices: America's new strategy. T. Normand, Sharon-Lise; Hatfield, Laura; Drozda, Joseph; S. Resnic, Frederic // BMJ: British Medical Journal;10/20/2012, Vol. 345 Issue 7879, p12 

    The article discusses the strategy of the U.S. FDA for postmarket surveillance of medical devices. The four-pronged strategy includes the establishment of device identification to facilitate tracking. Use of registries such as the transcatheter valve therapy registry affords potential to...

  • Cubist, Celgene Drugs on FDA Watch List.  // BioWorld Today;7/6/2010, Vol. 21 Issue 128, p3 

    The article offers information on the U.S. Food and Drug Administration's (FDA) watch list of products with potential safety issues, including the drugs Cubicin from Cubist Pharmaceuticals Inc., Vidaza from Celgene Corp. and Ranexa from Gilead Sciences Inc.

  • FDA WILL PROVIDE SAFETY UPDATES FOR APPROVED PRODUCTS.  // Contemporary Pediatrics;Jul2010, Vol. 27 Issue 7, p29 

    The article reports that the U.S. Food and Drug Administration (FDA) will provide safety analyses on approved products as well as updates on measures that the agency is taking to address safety issues.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics